Physician profile
Alison C May
NPI 1093843815
$1,001.19
in general payments reported to CMS, 2019-2025
13 companies · $874 in 2025
The $874 reported for 2025 was more than what 79% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $157.34 | 2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $126.98 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.83 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $88.70 | 2025 | Auvelity |
| Stryker Corporation | $76.92 | 2025 | Lifepak 15 Monitor/Defibrillator |
| Teva Pharmaceuticals USA, INC. | $70.57 | 2025 | Uzedy |
| Lundbeck LLC | $70.01 | 2025 | Rexulti |
| Indivior INC. | $68.00 | 2025 | Sublocade |
| Otsuka America Pharmaceutical, INC. | $66.53 | 2025 | Rexulti |
| Abbvie INC. | $64.08 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.31 | 2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $38.44 | 2025 | Hetlioz, Fanapt |
| Janssen Pharmaceuticals, INC | $31.48 | 2025 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.